As mentioned earlier, activation of the cGMP pathway is likely a crucial element in migraine and other headache pathogenesis, and CO, through cytoplasmic guanylate cyclase (sGC) stimulation, increases cGMP production, potentially leading to headache production. Here, SGCB is linked to migraine disorder.